Examkin

Question

Difficulty: MediumOrdering Laboratory Tests

A 62-year-old man is evaluated on the inpatient ward for new-onset right calf pain and swelling. Seven days ago, he was admitted for an acute anterior myocardial infarction and underwent a percutaneous coronary intervention. During the procedure and for the following 48 hours, he received intravenous unfractionated heparin. His other medications include aspirin, atorvastatin, and metoprolol. Vital signs are temperature 37.1°C (98.8°F), heart rate 92/min, blood pressure 130/80 mm Hg, and respiratory rate 16/min. Physical examination reveals an erythematous, swollen, and tender right calf. Venous duplex ultrasonography confirms a new acute deep vein thrombosis in the right popliteal vein. Laboratory studies obtained today show a platelet count of 95,000/mm³, which is decreased from a baseline of 220,000/mm³ on admission. Which of the following is the most appropriate next step in laboratory evaluation?

  1. Anti-platelet factor 4/heparin enzyme-linked immunosorbent assayAnswer
  2. B
    Serotonin release assay
  3. C
    Peripheral blood smear for schistocytes
  4. D
    Fibrinogen and D-dimer levels
  5. E
    Prothrombin time and activated partial thromboplastin time mixing study

Answer

Anti-platelet factor 4/heparin enzyme-linked immunosorbent assay
This patient's clinical presentation is highly suspicious for heparin-induced thrombocytopenia (HIT). He developed a relative thrombocytopenia (a drop of more than 50% from baseline) and a new deep vein thrombosis 7 days after initial exposure to unfractionated heparin. This yields a high '4T' score (Thrombocytopenia, Timing, Thrombosis, and absence of oTher causes). The clinical management of suspected HIT involves immediately discontinuing all heparin products and initiating an alternative non-heparin anticoagulant. For the diagnostic workup, the most appropriate initial laboratory evaluation is an anti-platelet factor 4 (PF4)/heparin enzyme-linked immunosorbent assay (ELISA). This immunoassay is highly sensitive and serves as an excellent screening test. If the initial ELISA is positive, a functional assay (such as the serotonin release assay) is then ordered to definitively confirm the diagnosis.

Step-by-Step Solution

1
Calculate the clinical probability of heparin-induced thrombocytopenia (HIT) using the 4T score.
The patient has a platelet count drop of >50% (2 points), timing of 5-10 days after heparin exposure (2 points), and a new thrombosis (2 points), yielding a high clinical probability score.
A high 4T score indicates a strong suspicion for HIT, guiding the clinician to immediately halt heparin and begin diagnostic laboratory testing.
2
Identify the standard diagnostic algorithm for the laboratory evaluation of suspected HIT.
The algorithm requires ordering an initial screening laboratory test, followed by a confirmatory functional assay only if the initial screen is positive.
Proper test sequencing prevents delays in diagnosis and avoids the unnecessary utilization of expensive, slow-turnaround confirmatory assays.
3
Select the most appropriate initial laboratory test.
The anti-platelet factor 4/heparin enzyme-linked immunosorbent assay (ELISA) is the correct choice.
As a highly sensitive immunoassay, it rapidly determines if HIT antibodies are present, serving as a reliable initial diagnostic screening step.

Key Concept

The initial laboratory evaluation for clinically suspected heparin-induced thrombocytopenia utilizes a highly sensitive screening test, such as the anti-platelet factor 4/heparin ELISA, prior to pursuing a highly specific confirmatory functional assay.
Rate this question

Topics

Ordering Laboratory Tests

More questions from this topic